Cancer patients should be screened for hepatitis B
Added: Saturday 7 January 2012
Prophylactic antivirals to treat hepatitis B can reduce mortality in cancer patients - but treatment must happen before chemotherapy begins. However, less than a fifth of chemotherapy patients in a recent study had been screened for hepatitis B before treatment started. The San Francisco study shows that preventable reactivation of hepatitis B does occur in chemotherapy patients and that screening is a simple solution to prevent potentially life-threatening complications.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: